A critical breakthrough in cancer research is occurring with the use of nanobodies to re-engage mutated p53. This essential cancer suppressor protein is frequently disabled in various forms of tumors, causing https://bookmarkextent.com/story24144763/vhh-fragments-reactivate-tumor-suppressor-p53-new-potential-pathway-for-tumor-management